when was semaglutide discovered 30 years of obesity research and over 100 years of medical breakthroughs. Learn more about and the story behind the discovery here: https://lnkd.in/e_as9aKV | Novo Nordisk New obesity drug semaglutide is

A Body Mass Index (BMI) of 30 or greater (classified as obesity)

If your brain isn't trained with your body, then you're not doing anything. She found it easier to shed baby weight after giving birth a second time

In other words, look at the brain in ways we could not look at 20 years ago

Although these drugs were initially developed for the treatment of type 2 diabetes, clinical studies have largely demonstrated their beneficial effects in metabolic, renal, and cardiovascular diseases that go beyond glucose control (Minze et al., 2018

It is theoretically possible that pharmacological manipulation of these receptors could influence mood and behaviour

We accept In stock Ships today if ordered by 3 PM EST USA fulfillment COA on request 3rd-party tested 24 h dispatch Certificate of Analysis current lot Verified Batch / Lot # GP-9C43-2026 Test date April 13, 2026 Laboratory Freedom Diagnostics Identity / Purity (HPLC) 98.50% Mass confirmation (LC-MS) Match Endotoxin (LAL, USP ) 0.24 EU/mg Residual solvents (USP ) Pass Water content (KF) Pass Description Reviews Retatrutide 10 mg Research Grade Retatrutide is a synthetic triple-agonist research peptide that targets the GLP-1, GIP, and glucagon receptors simultaneously